Contact HealthDay
Tel: 203.855.1400 or E-mail

News By Specialty

Allergy
Anesthesiology
Cardiology
Cosmetic Surgery
Critical Care
Dermatology
Diabetes & Endocrinology
Emergency Medicine
Family Practice
Gastroenterology
Geriatrics
Hematology & Oncology
HIV & AIDS
Infectious Disease
Internal Medicine
Nephrology
Neurology
Nursing
OBGYN & Women's Health
Ophthalmology
Orthopedics
Otolaryngology
Pain Management
Pathology
Pediatrics
Pharmacy
Psychiatry
Pulmonology
Radiology
Rheumatology
Surgery
Urology

Follow us on:

    


e-Healthcare Leadership Awards


Natalizumab Shows Promise for Teens With Multiple Sclerosis
Significant reductions in average annualized relapse rates seen with treatment
This article is older than one year and is no longer available.

Copyright © 2013 HealthDay. All rights reserved.

January 28, 2015

Archive Search

By Keyword:
By Category:
By Topic:

Related Articles

FDA Approves New Meningococcal Disease Vaccine

Premature Death Risk Up for Stroke Survivors Living Alone

Sedation Protocol Doesn't Reduce Duration of Ventilation in PICU

FDA Approves Generic Form of Nexium

Cumulative Use of Anticholinergic Medication Tied to Dementia

Provider Demographics Affect Pain Treatment Decisions